Associate ProfessorUniversity of Pennsylvania, United States
8: A high pre-existing TCR repertoire diversity may predict response to preoperative radiotherapy and pembrolizumab in early-stage breast cancer – NCT04454528 preliminary results
Friday, March 22, 202410:52am – 11:02am ET
5: Change in Biomarker Profile after neoadjuvant chemotherapy is especially common in patients with HER2+ breast cancer subtype
Friday, March 22, 202411:02am – 11:12am ET
